Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia

Journal of Experimental Medicine

Volumn 205, Issue 4, 2008, Pages 751-758

  Flex, Elisabetta ^a   Petrangeli, Valentina ^a   Stella, Lorenzo ^b   Chiaretti, Sabina ^c   Hornakova, Tekla ^d   Knoops, Laurent ^d   Ariola, Cristina ^c   Fodale, Valentina ^a   Clappier, Emmanuelle ^e   Paoloni, Francesca ^f   Martinelli, Simone ^a   Fragale, Alessandra ^a   Sanchez, Massimo ^a   Tavolaro, Simona ^c   Messina, Monica ^c   Cazzaniga, Giovanni ^g   Camera, Andrea ^h   Pizzolo, Giovanni ⁱ   Tornesello, Assunta ^j   Vignetti, Marco ^c   Battistini, Angela ^a   Cavé, Hélène ^e   Gelb, Bruce D ^k   Renauld, Jean Christophe ^d   Biondi, Andrea ^g   Constantinescu, Stefan N ^d   Foà, Robin ^c   Tartaglia, Marco ^a   more..

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e HÔPITAL ROBERT DEBRÉ   (France)

^f GIMEMA Foundation   (Italy)

^g UNIVERSITY OF MILANO BICOCCA   (Italy)

^h UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁱ UNIVERSITY OF VERONA   (Italy)

^j CATHOLIC UNIVERSITY   (Italy)

^k MOUNT SINAI SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; INTERLEUKIN 3; INTERLEUKIN 9; JANUS KINASE 1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLELE; ANIMAL CELL; APOPTOSIS; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; LEUKEMIA CELL; LEUKEMOGENESIS; LYMPHOMA CELL; MISSENSE MUTATION; MOLECULAR MODEL; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; T CELL LYMPHOMA; T LYMPHOCYTE; TREATMENT RESPONSE; UPREGULATION;

ALLELES; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; JANUS KINASE 1; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 42249091014     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20072182     Document Type: Article

References (28)

1. Armstrong, S.A., and A.T. Look. 2005. Molecular genetics of acute lymphoblastic leukemia. J. Clin. Oncol. 23:6306-6315.
2. Pui, C.H., and W.E. Evans. 2006. Treatment of acute lymphoblastic leukemia. N. Engl. J. Med. 354:166-178.
3. Yeoh, E.J., M.E. Ross, S.A. Shurtleff, W.K. Williams, D. Patel, R. Mahfouz, F.G. Behm, S.C. Raimondi, M.V. Relling, A. Patel, et al. 2002. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 1:133-143.
4. Vitale, A., A. Guarini, S. Chiaretti, and R. Foa. 2006. The changing scene of adult acute lymphoblastic leukemia. Curr. Opin. Oncol. 18:652-659.
5. Chiaretti, S., X. Li, R. Gentleman, A. Vitale, M. Vignetti, F. Mandelli, J. Ritz, and R. Foa. 2004. Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood. 103:2771-2778.
6. Thomas, X. 2005. Emerging drugs for adult acute lymphoblastic leukaemia. Expert Opin. Emerg. Drugs. 10:591-617.
7. Yamaoka, K., P. Saharinen, M. Pesu, V.E. Holt III, O. Silvennoinen, and J.J. O'Shea. 2004. The Janus kinases (Jaks). Genome Biol. 5:253.
8. Schindler, C., D.E. Levy, and T. Decker. 2007. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282:20059-20063.
9. Murray, P.J. 2007. The JAK-STAT signalling pathway: Input and output integration. J. Immunol. 178:2623-2629.
10. Rodig, S.J., M.A. Meraz, J.M. White, P.A. Lampe, J.K. Riley, C.D. Arthur, K.L. King, K.C. Sheehan, L. Yin, D. Pennica, et al. 1998. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell. 93:373-383.
11. Müller, M., J. Briscoe, C. Laxton, D. Guschin, A. Ziemiecki, O. Silvennoinen, A. Harpur, G. Barbieri, B.A. Witthuhn, C. Schindler, S. Pellegrini, A.F. Wilks, J.N. Ihle, G.R. Stark, and L.M. Kerr. 1993. The protein tyrosine kinase JAK1 complements defects in interferonalpha/beta and -gamma signal transduction. Nature. 366:129-135.
12. Renauld, J.C., A. Vink, J. Louahed, and J. Van Snick. 1995. Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas. Blood. 85:1300-1305.
13. Demoulin, J.B., C. Uyttenhove, E. Van Roost, B. DeLestre, D. Donckers, J. Van Snick, and J.C. Renauld. 1996. A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9. Mol. Cell. Biol. 16:4710-4716.
14. Giordanetto, F., and R.T. Kroemer. 2002. Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 though 7. Protein Eng. 15:727-737.
15. Chen, M., A. Cheng, F. Candotti, Y.J. Zhou, A. Hymel, A. Fasth, L.D. Notarangelo, and J.J. O'Shea. 2000. Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains. Mol. Cell. Biol. 20:947-956.
16. Lindauer, K., T. Loerting, K.R. Liedl, and R.T. Kroemer. 2001. Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation. Protein Eng. 14:27-37.
17. Saharinen, P., and O. Silvennoinen. 2002. The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction. J. Biol. Chem. 277:47954-47963.
18. James, C., V. Ugo, J.P. Le Couedic, J. Staerk, F. Delhommeau, C. Lacout, L. Garcon, H. Raslova, R. Berger, A. Bennaceur-Griscelli, et al. 2005. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 434:1144-1148.
19. Levine, R.L., M. Wadleigh, J. Cools, B.L. Ebert, G. Wernig, B.J. Huntly, T.J. Boggon, I. Wlodarska, J.J. Clark, S. Moore, et al. 2005. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 7:387-397.
20. Walters, D.K., T. Mercher, T.L. Gu, T. O'Hare, J.W. Tyner, M. Loriaux, V.L. Goss, K.A. Lee, C.A. Eide, M.J. Wong, et al. 2006. Activating alleles of JAK3 in acute megakaryoblastic leukemia. Cancer Cell. 10:65-75.
21. Radtke, S., S. Haan, A. Jorissen, H.M. Hermanns, S. Diefenbach, T. Smyczek, H. Schmitz-Vandeleur, P.C. Heinrich, I. Behrmann, and C. Haan. 2005. The Jak1 SH2 domain does not fulfill a classical SH2 function in Jak/STAT signaling but plays a structural role for receptor interaction and upregulation of receptor surface expression. J. Biol. Chem. 280:25760-25768.
22. Haan, C., H. Is'harc, H.M. Hermanns, H. Schmitz-Van De Leur, I.M. Kerr, P.C. Heinrich, J. Grotzinger, and I. Behrmann. 2001. Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction. J. Biol. Chem. 276:37451-37458.
23. Zhou, Y.J., M. Chen, N.A. Cusack, L.H. Kimmel, K.S. Magnuson, J.G. Boyd, W. Lin, J.L. Roberts, A. Lengi, R.H. Buckley, et al. 2001. Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases. Mol. Cell. 8:959-969.
24. Levine, R.L., M. Loriaux, B.J. Huntly, M.L. Loh, M. Beran, E. Stoff regen, R. Berger, J.J. Clark, S.G. Willis, K.T. Nguyen, et al. 2005. The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia. Blood. 106:3377-3379.
25. Gokbuget, N., and D. Hoelzer. 2006. Treatment of adult acute lymphoblastic leukemia. Hematology (Am Soc Hematol Educ Program). 133-141.
26. Baldus, C.D., T. Burmeister, P. Martus, S. Schwartz, N. Gokbuget, C.D. Bloomfield, D. Hoelzer, E. Thiel, and W.K. Hofmann. 2006. High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults. J. Clin. Oncol. 24:4714-4720.
27. Ferrando, A.A., D.S. Neuberg, R.K. Dodge, E. Paietta, R.A. Larson, P.H. Wiernik, J.M. Rowe, M.A. Caligiuri, C.D. Bloomfield, and A.T. Look. 2004. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia. Lancet. 363:535-536.
28. Zhu, Y.M., W.L. Zhao, J.F. Fu, J.Y. Shi, Q. Pan, J. Hu, X.D. Gao, B. Chen, J.M. Li, S.M. Xiong, et al. 2006. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis. Clin. Cancer Res. 12:3043-3049.